NEW YORK, Sept 25 – Genzyme Molecular Oncology (Nasdaq: GZMO) said Monday it had licensed its gene expression database, SAGE, to Celera Genomics (NYSE: CRA) for distribution through the Celera Discovery System on a revenue sharing basis.

The SAGE database includes information on over 2.5 million gene sequences from cancerous and healthy tissues. Genzyme of Farmingham, Mass., will continue to provide Celera with additional SAGE data as the database expands.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.